Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins.

Fochi S, Bergamo E, Serena M, Mutascio S, Journo C, Mahieux R, Ciminale V, Bertazzoni U, Zipeto D, Romanelli MG.

Front Microbiol. 2019 Jun 12;10:1302. doi: 10.3389/fmicb.2019.01302. eCollection 2019.

2.

Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.

Cecconi D, Brandi J, Manfredi M, Serena M, Carbonare LD, Deiana M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Avanzi F, Antoniazzi F, Marengo E, Tiso N, Mottes M, Zipeto D, Valenti MT.

Sci Rep. 2019 May 29;9(1):8052. doi: 10.1038/s41598-019-44552-1.

3.

Inflammation and Metabolism in Cancer Cell-Mitochondria Key Player.

Neagu M, Constantin C, Popescu ID, Zipeto D, Tzanakakis G, Nikitovic D, Fenga C, Stratakis CA, Spandidos DA, Tsatsakis AM.

Front Oncol. 2019 May 14;9:348. doi: 10.3389/fonc.2019.00348. eCollection 2019. Review.

4.

Inflammation in Cancer: Part of the Problem or Part of the Solution?

Neagu M, Zipeto D, Popescu ID.

J Immunol Res. 2019 Feb 7;2019:5403910. doi: 10.1155/2019/5403910. eCollection 2019. No abstract available.

5.

RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3.

Lorenzi P, Sangalli A, Fochi S, Dal Molin A, Malerba G, Zipeto D, Romanelli MG.

Int J Biochem Cell Biol. 2019 Jan;106:74-83. doi: 10.1016/j.biocel.2018.11.009. Epub 2018 Nov 20.

PMID:
30468920
6.

New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.

Deiana M, Dalle Carbonare L, Serena M, Cheri S, Parolini F, Gandini A, Marchetto G, Innamorati G, Manfredi M, Marengo E, Brandi J, Cecconi D, Mori A, Mina MM, Antoniazzi F, Mottes M, Tiso N, Malerba G, Zipeto D, Valenti MT.

Cells. 2018 Nov 20;7(11). pii: E220. doi: 10.3390/cells7110220.

7.

HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β2-Microglobulin a Missing Piece of the Pathogenetic Puzzle?

Zipeto D, Serena M, Mutascio S, Parolini F, Diani E, Guizzardi E, Muraro V, Lattuada E, Rizzardo S, Malena M, Lanzafame M, Malerba G, Romanelli MG, Tamburin S, Gibellini D.

Front Neurol. 2018 Sep 21;9:791. doi: 10.3389/fneur.2018.00791. eCollection 2018.

8.

Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity".

Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, Cazzoletti L, Scupoli MT, Gibellini D, Ugolotti E, Biassoni R, Beretta A, Malnati M, Romanelli MG, Zipeto D.

J Virol. 2018 Aug 16;92(17). pii: e00911-18. doi: 10.1128/JVI.00911-18. Print 2018 Sep 1. No abstract available.

9.

Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.

Serena M, Parolini F, Biswas P, Sironi F, Blanco Miranda A, Zoratti E, Scupoli MT, Ziglio S, Valenzuela-Fernandez A, Gibellini D, Romanelli MG, Siccardi A, Malnati M, Beretta A, Zipeto D.

Sci Rep. 2018 May 22;8:46991. doi: 10.1038/srep46991.

10.

HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role.

Fochi S, Mutascio S, Bertazzoni U, Zipeto D, Romanelli MG.

Front Microbiol. 2018 Feb 21;9:285. doi: 10.3389/fmicb.2018.00285. eCollection 2018. Review.

11.

Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.

Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, Cazzoletti L, Scupoli MT, Gibellini D, Ugolotti E, Biassoni R, Beretta A, Malnati M, Romanelli MG, Zipeto D.

J Virol. 2017 Dec 14;92(1). pii: e01711-17. doi: 10.1128/JVI.01711-17. Print 2018 Jan 1. Erratum in: J Virol. 2018 Aug 16;92(17):.

12.

IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia.

Piccaluga PP, Agostinelli C, Righi S, Ciccone M, Re MC, Musumeci G, Diani E, Signoretto C, Bon I, Piccin O, Cuneo A, Tripodo C, Ponti C, Zipeto D, Landolfo S, Gibellini D.

APMIS. 2017 Jun;125(6):511-522. doi: 10.1111/apm.12692. Epub 2017 May 18.

PMID:
28517553
13.

HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.

Serena M, Parolini F, Biswas P, Sironi F, Blanco Miranda A, Zoratti E, Scupoli MT, Ziglio S, Valenzuela-Fernandez A, Gibellini D, Romanelli MG, Siccardi A, Malnati M, Beretta A, Zipeto D.

Sci Rep. 2017 Jan 4;7:40037. doi: 10.1038/srep40037. Erratum in: Sci Rep. 2018 May 22;8:46991.

14.

Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays.

Serena M, Giorgetti A, Busato M, Gasparini F, Diani E, Romanelli MG, Zipeto D.

Sci Rep. 2016 Mar 1;6:22319. doi: 10.1038/srep22319.

15.

Comment on "Influence of HLA-C expression level on HIV control".

Lo Monaco E, Tremante E, Biswas P, Cranage MP, Zipeto D, Beretta A, Giacomini P.

Science. 2013 Sep 13;341(6151):1175. doi: 10.1126/science.1241266.

16.

Gelsolin activity controls efficient early HIV-1 infection.

García-Expósito L, Ziglio S, Barroso-González J, de Armas-Rillo L, Valera MS, Zipeto D, Machado JD, Valenzuela-Fernández A.

Retrovirology. 2013 Apr 10;10:39. doi: 10.1186/1742-4690-10-39.

17.

HLA-C and HIV-1: friends or foes?

Zipeto D, Beretta A.

Retrovirology. 2012 May 9;9:39. doi: 10.1186/1742-4690-9-39. Review.

18.

HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes.

Baroni M, Matucci A, Scarlatti G, Soprana E, Rossolillo P, Lopalco L, Zipeto D, Siccardi AG, De Santis C.

J Gen Virol. 2010 Jan;91(Pt 1):235-41. doi: 10.1099/vir.0.015230-0. Epub 2009 Sep 23.

PMID:
19776241
19.

Analysis of colorectal cancers for human cytomegalovirus presence.

Bender C, Zipeto D, Bidoia C, Costantini S, Zamò A, Menestrina F, Bertazzoni U.

Infect Agent Cancer. 2009 Apr 16;4:6. doi: 10.1186/1750-9378-4-6.

20.

Unsung hero Robert C. Gallo.

Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

Science. 2009 Jan 9;323(5911):206-7. doi: 10.1126/science.323.5911.206. No abstract available.

PMID:
19131607
21.

HLA-C increases HIV-1 infectivity and is associated with gp120.

Matucci A, Rossolillo P, Baroni M, Siccardi AG, Beretta A, Zipeto D.

Retrovirology. 2008 Aug 1;5:68. doi: 10.1186/1742-4690-5-68.

22.

Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes.

Zipeto D, Matucci A, Ripamonti C, Scarlatti G, Rossolillo P, Turci M, Sartoris S, Tridente G, Bertazzoni U.

Microbes Infect. 2006 May;8(6):1424-33. Epub 2006 Apr 18.

PMID:
16702010
23.

Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.

Turci M, Pilotti E, Ronzi P, Magnani G, Boschini A, Parisi SG, Zipeto D, Lisa A, Casoli C, Bertazzoni U.

J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):100-6.

PMID:
16340481
24.

Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.

Bodaghi B, Slobbe-van Drunen ME, Topilko A, Perret E, Vossen RC, van Dam-Mieras MC, Zipeto D, Virelizier JL, LeHoang P, Bruggeman CA, Michelson S.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2598-607.

PMID:
10509655
25.

Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.

Zipeto D, Bodaghi B, Laurent L, Virelizier JL, Michelson S.

J Gen Virol. 1999 Mar;80 ( Pt 3):543-7.

PMID:
10091991
26.
27.

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells.

Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S.

J Exp Med. 1998 Sep 7;188(5):855-66.

28.

Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients.

Zipeto D, Hong C, Gerna G, Zavattoni M, Katzenstein D, Merigan TC, Rasmussen L.

AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):533-6.

PMID:
9566556
29.

Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood.

Rasmussen L, Zipeto D, Wolitz RA, Dowling A, Efron B, Merigan TC.

J Infect Dis. 1997 Nov;176(5):1146-55.

PMID:
9359712
30.

Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Michelson S, Dal Monte P, Zipeto D, Bodaghi B, Laurent L, Oberlin E, Arenzana-Seisdedos F, Virelizier JL, Landini MP.

J Virol. 1997 Sep;71(9):6495-500.

31.

Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients.

Rasmussen L, Hong C, Zipeto D, Morris S, Sherman D, Chou S, Miner R, Drew WL, Wolitz R, Dowling A, Warford A, Merigan TC.

J Infect Dis. 1997 Jan;175(1):179-84.

PMID:
8985216
32.

Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes.

Zipeto D, Morris S, Hong C, Dowling A, Wolitz R, Merigan TC, Rasmussen L.

J Clin Microbiol. 1995 Oct;33(10):2607-11.

33.

Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

Rasmussen L, Morris S, Zipeto D, Fessel J, Wolitz R, Dowling A, Merigan TC.

J Infect Dis. 1995 Jan;171(1):177-82.

PMID:
7798658
34.

Identification of human cytomegalovirus strain with immediate-early (IE) antigen-specific monoclonal antibody is prevented by point mutation in IE gene.

Zipeto D, Sarasini A, Rossi F, Baldanti F, Revello MG, Milanesi G, Gerna G.

J Clin Microbiol. 1994 May;32(5):1402-5.

36.

Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction.

Zipeto D, Baldanti F, Zella D, Furione M, Cavicchini A, Milanesi G, Gerna G.

J Virol Methods. 1993 Sep;44(1):45-55.

PMID:
8227278
37.

Identification of a human cytomegalovirus mutant in the pp150 matrix phosphoprotein gene with a growth-defective phenotype.

Zipeto D, Baldanti F, Percivalle E, Gerna G, Milanesi G.

J Gen Virol. 1993 Aug;74 ( Pt 8):1645-8.

PMID:
8393916
38.

Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients.

Gerna G, Zipeto D, Percivalle E, Parea M, Revello MG, Maccario R, Peri G, Milanesi G.

J Infect Dis. 1992 Dec;166(6):1236-44.

PMID:
1331248
39.
40.
41.

Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.

Gerna G, Zipeto D, Parea M, Revello MG, Silini E, Percivalle E, Zavattoni M, Grossi P, Milanesi G.

J Infect Dis. 1991 Sep;164(3):488-98.

PMID:
1651361
42.

Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection.

Gerna G, Parea M, Percivalle E, Zipeto D, Silini E, Barbarini G, Milanesi G.

AIDS. 1990 Oct;4(10):1027-31.

PMID:
2175616
43.

Identification of human cytomegalovirus isolates by the polymerase chain reaction.

Zipeto D, Silini E, Parea M, Percivalle E, Zavattoni M, Di Matteo A, Milanesi G, Gerna G.

Microbiologica. 1990 Oct;13(4):297-304.

PMID:
1965006

Supplemental Content

Loading ...
Support Center